Package | us.nlm.vsac |
Type | ValueSet |
Id | 2.16.840.1.113762.1.4.1248.204 |
FHIR Version | R4 |
Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1248.204/expansion |
URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.204 |
Version | 20240604 |
Status | active |
Date | 2024-06-04T01:21:19-04:00 |
Name | VTEProphylaxis |
Title | VTE Prophylaxis |
Realm | us |
Authority | hl7 |
Purpose | (Clinical Focus: The purpose of this value set is to represent concepts for medications for venous thromboembolism (VTE) prophylaxis.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent injectable and oral medications considered to be VTE prophylaxis medications.),(Exclusion Criteria: No exclusions) |
No resources found
CodeSystem | |
rxnorm | RxNorm |
rxnorm | RxNorm |
ValueSet | |
2.16.840.1.113762.1.4.1045.39 | Low Dose Unfractionated Heparin for VTE Prophylaxis |
2.16.840.1.113762.1.4.1045.41 | Glycoprotein IIb IIIa Inhibitors |
2.16.840.1.113762.1.4.1110.50 | Rivaroxaban for VTE Prophylaxis |
2.16.840.1.113883.3.117.1.7.1.134 | Oral Factor Xa Inhibitor for VTE Prophylaxis or VTE Treatment |
2.16.840.1.113883.3.117.1.7.1.205 | Direct Thrombin Inhibitor |
2.16.840.1.113883.3.117.1.7.1.211 | Injectable Factor Xa Inhibitor for VTE Prophylaxis |
2.16.840.1.113883.3.117.1.7.1.218 | Unfractionated Heparin |
2.16.840.1.113883.3.117.1.7.1.219 | Low Molecular Weight Heparin for VTE Prophylaxis |
2.16.840.1.113883.3.117.1.7.1.232 | Warfarin |
No narrative content found in resource